Tag: ALK inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to ALK inhibitor

Pfizer (PFE) Lorviqua Gets EU Nod for First-Line Lung Cancer - Entrepreneur

Added to Collection on: 2022-01-31 18:16:09

Tags for this article:

Chemical compounds
Organic compounds
Chemistry
Breakthrough therapy
Piperidines
Lung cancer
Tyrosine kinase receptors
Ceritinib
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Alectinib

Click the tags to see associated articles and topics

View Article Details
The Zacks Analyst Blog Highlights: AbbVie, Merck, Eli Lilly, Novartis and Pfizer - Entrepreneur

Added to Collection on: 2022-02-08 01:05:12

Tags for this article:

Life Sciences
Health sciences
Health care
Pfizer
ALK inhibitor
Pharmaceutical industry
AbbVie
Eli Lilly and Company
Lorlatinib
Securities research
Anaplastic lymphoma kinase
Angi Inc.

Click the tags to see associated articles and topics

View Article Details
Pfizer's Lorbrena shows PFS improvement in Phase III lung cancer trial

Added to Collection on: 2022-04-11 14:12:56

Tags for this article:

Chemical compounds
Organic compounds
Aromatic compounds
Lung cancer
Tyrosine kinase receptors
Piperidines
ALK inhibitor
Orphan drugs
Anaplastic lymphoma kinase
Crizotinib
Lorlatinib
Non-small-cell lung carcinoma
XALKORI
pfizer global

Click the tags to see associated articles and topics

View Article Details
A novel IGR-ALK fusion in a patient with lung adenocarcinoma | OTT - Dove Medical Press

Added to Collection on: 2024-03-26 16:24:41

Tags for this article:

Lung cancer
CYP3A4 inhibitors
Pyrazoles
Piperidines
Orphan drugs
ALK inhibitor
Anaplastic lymphoma kinase
Crizotinib
Ceritinib
Adenocarcinoma of the lung
Non-small-cell lung cancer
Alectinib

Click the tags to see associated articles and topics

View Article Details
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the ... - Placera

Added to Collection on: 2024-11-20 14:39:25

Tags for this article:

Lung cancer
ALK inhibitor
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Alectinib
Small-cell carcinoma
Cancer research
ALK positive lung cancer
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with ... - PR Newswire

Added to Collection on: 2024-11-20 14:34:06

Tags for this article:

Lung cancer
ALK inhibitor
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Alectinib
Small-cell carcinoma
ALK positive lung cancer
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
Genprex Signs Exclusive License to Additional Gene Therapy Technologies ... - Star Local Media

Added to Collection on: 2024-11-20 15:37:02

Tags for this article:

Lung cancer
Tyrosine kinase receptors
Anaplastic lymphoma kinase
ALK
Gene therapy
ALK positive lung cancer
ALK inhibitor
Genprex Inc.

Click the tags to see associated articles and topics

View Article Details
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates

Added to Collection on: 2025-01-24 15:50:32

Tags for this article:

Orphan drugs
CYP3A4 inhibitors
Cystic fibrosis
Antineoplastic drugs
Durvalumab
Ivacaftor
Tezacaftor
Respiratory syncytial virus
ALK inhibitor
Non-small-cell lung cancer
Crizotinib
Anaplastic lymphoma kinase

Click the tags to see associated articles and topics

View Article Details
Strategic and Safe Lorlatinib Use Is Key to Optimal ALK+ NSCLC Management - OncLive

Added to Collection on: 2025-02-21 21:19:48

Tags for this article:

Pyrazoles
Orphan drugs
Lung cancer
Tyrosine kinase receptors
Antineoplastic drugs
Lorlatinib
ALK inhibitor
Crizotinib
Anaplastic lymphoma kinase
Non-small-cell lung cancer
ALK positive lung cancer
ROS1
Alectinib

Click the tags to see associated articles and topics

View Article Details
Velcheti Evaluates Activity of Repotrectinib for ROS1 Fusion–Positive NSCLC

Added to Collection on: 2025-03-15 15:07:04

Tags for this article:

Tyrosine kinase receptors
Antineoplastic drugs
ROS1
Orphan drugs
Ethers
Amines
ALK inhibitor
Entrectinib
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Crizotinib
Gefitinib

Click the tags to see associated articles and topics

View Article Details